Major drugmaker loses $27 billion in market value after failed trial
MarketWatchPaywall
Read Full Article at MarketWatch →Ad Slot — In-Article (728x90)
Two companies announced on Thursday that the heart-disease drug they had been developing failed its Phase 3 trial.
This is a summary. For the full story, read the original article at MarketWatch.
Original source: MarketWatch